2023
DOI: 10.17650/1726-9776-2023-19-1-25-34
|View full text |Cite
|
Sign up to set email alerts
|

Retroperitoneoscopic access in organ-preserving treatment of renal cell carcinoma

Abstract: Background. Renal cell carcinoma is one of the most common urologic cancers. Due to development of modern diagnostic methods, kidney tumors are often diagnosed at early stages (cT1a-T1b). The golden standard of treatment of localized renal cell carcinoma is tumor resection. In retroperitoneoscopic access, the time to artery access is decreased, the risk of intra- and postoperative complications is reduced. Retroperitoneal access is preferable for tumors located on the lateral or posterior kidney surface.Aim. T… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 23 publications
(21 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?